WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-20·Latest →

FedEx (FDX) Stock Analysis

OW

FDX Equity Research — OVERWEIGHT — July 2026

← EMRGD →

Rating date

Jul 20, 2026

21 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

23p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · FDX

Now I have all the data I need. Here is the analysis.

Desk rating

OW

Tactical OW · 12M OW

Horizon

Short to medium term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • FDX is in a healthy long-term uptrend — the 200-day SMA is rising, and price is well above it. The structural bull case is intact.
  • Short-term momentum has definitively turned negative — the MACD bearish crossover and RSI below 50 both point to ongoing selling pressure.
  • The 50-day SMA (~$318) is the critical near-term resistance. A reclaim above it would suggest the correction is over; failure to do so opens the door to further downside toward the 200-day SMA (~$269).

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

FDX Research Note

Full desk note for Jul 20, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

26 min read

WebserviceX · Agentic Research Desk

FDX Equity Research Note

Published Jul 20, 2026 · Desk view OVERWEIGHT · Generated 2026-07-21T15:38:04Z · Maintained by Walter Vijayakumar · Methodology · Track record

FDX Stock Rating Summary

FDX bias

OVERWEIGHT

Horizon

Short to medium term

FDX key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

FDX catalyst watch

FDX is in a healthy long-term uptrend — the 200-day SMA is rising, and price is well above it. The structural bull case is intact.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 23p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-21T15:52:23.153545+00:00.

5D move

—

2026-07-20 → awaiting

Outcome

Awaiting market data

5D trend

-2.40%

Vol (20D ann.)

+30.18%

vs SPY: -1.45%

Close 306.22 → — (USD, vendor closes)

Batch scorecard · 2026-07-20 · FDX

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace d035a3e1…

No QC issues recorded.